What we do.
Founded in 2006 and headquartered in Raleigh, North Carolina, Valencell develops performance biometric data sensors and licenses its patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell’s PerformTek-powered sensors are the most accurate wearable biometric sensors that continuously measure heart rate and activity. Valencell has invested years into research and development of its PerformTek sensors, which have been validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.
The company is led by CEO Michael Dering who brings decades of significant experience with both public and private equity-backed companies. This experience is coupled with the deep technical expertise of President Dr. Steven LeBoeuf and his co-founding team of scientists and engineers that have been augmented further with R&D talent since the company was formed in 2006. During that time, Valencell has built an impressive portfolio of patents that are now critical to high accuracy in biometric data sensors and recognized as key for manufacturers to compete effectively in the wearables market.
Since being founded in 2006, the company has raised more than $13 million in venture funding from WSJ Joshua Fund, Best Buy Capital, TDF Ventures and True Ventures. The company has also secured more than $3 million in grants.